The ASX has been up 0.2% at around 8,140 points in morning trade.
Dimerix (ASX:DMX) has rocketed up around 47% and is the most watched on HotCopper after inking a deal with Nasdaq listed Amicus Therapeutics. The deal will see the commercialisation of Dimerix’ Phase 3 drug candidate DMX-200 for all indications in the United States.
Andromeda Metals (ASX:ADN) has also been trending on news it has progressed its plan to commercialise the production of the critical mineral high purity alumina.
Andromeda Metals has been up 71% at 2.4 cents.
And, finally Dreadnought (ASX:DRE) has been down 3.3% on news an Agreement has been executed to fund up to $15M of exploration expenditure at the Money Intrusion, part of the Mangaroon project, in the Gascoyne region of WA.
Dreadnought has been 1.5 cents in lunchtime trade.